Results 111 to 120 of about 11,489 (193)

Modified Vaccinia Virus Ankara as a Potential Biosafety Level 2 Surrogate for African Swine Fever Virus in Disinfectant Efficacy Tests. [PDF]

Pathogens, 2022
Rhee CH, Her M, Jeong W.
europepmc   +1 more source

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara. [PDF]

Pharmaceuticals (Basel), 2022
Jiménez de Oya N, Pérez P, Blázquez AB, Escribano-Romero E, Esteban M, Saiz JC, García-Arriaza J, Martín-Acebes MA.   +7 more
europepmc   +1 more source

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara

, 1996
Vanessa M. Hirsch, Thomas R. Fuerst, Gerd Sutter, Miles W. Carroll, Lijuan Yang, S Goldstein, M. Piatak, William R. Elkins, W. Gregory Alvord, David C. Montefiori, Bernard Moss, Jeff Lifson   +11 more
openalex   +1 more source

Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis [PDF]

, 2005
Silke Fischer, Holger Ludwig, J. Holzapfel, Marc Kvansakul, L Chen, David C.S. Huang, Gerd Sutter, M Knese, Georg Häcker   +8 more
openalex   +1 more source

Retraction: Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome. [PDF]

PLoS Pathog, 2022
PLOS Pathogens Editors.
europepmc   +1 more source

Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen

, 1999
Tomáš Hanke, Rachel V. Samuel, Tom Blanchard, Veronica Neumann, Todd M. Allen, Jon E. Boyson, Sally Sharpe, Nicola Cook, Geoffrey L. Smith, David I. Watkins, Martin Cranage, Andrew J. McMichael   +11 more
openalex   +1 more source

Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA). [PDF]

Cell Death Dis, 2021
Klaas L, Vier J, Gentle IE, Häcker G, Kirschnek S.   +4 more
europepmc   +1 more source

Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells. [PDF]

J Virol, 2021
Erez N, Wyatt LS, Americo JL, Xiao W, Moss B.   +4 more
europepmc   +1 more source

Expression of CCL20 and Granulocyte-Macrophage Colony-Stimulating Factor, but Not Flt3-L, from Modified Vaccinia Virus Ankara Enhances Antiviral Cellular and Humoral Immune Responses [PDF]

, 2006
Rahul Chavan, Kavita A. Marfatia, InChul An, David A. Garber, Mark B. Feinberg   +4 more
openalex   +1 more source

Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial. [PDF]

Lancet Microbe, 2022
Chiuppesi F, Zaia JA, Frankel PH, Stan R, Drake J, Williams B, Acosta AM, Francis K, Taplitz RA, Dickter JK, Dadwal S, Puing AG, Nanayakkara DD, Ash P, Cui Y, Contreras H, La Rosa C, Tiemann K, Park Y, Medina J, Iniguez A, Zhou Q, Karpinski V, Johnson D, Faircloth K, Kaltcheva T, Nguyen J, Kha M, Nguyen VH, Francisco SO, Grifoni A, Wong A, Sette A, Wussow F, Diamond DJ.   +34 more
europepmc   +1 more source